NCT00477451View on ClinicalTrials.gov

Staccato Alprazolam in Panic Attack

PHASE2CompletedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

April 30, 2008

Study Completion Date

April 30, 2008

Conditions
Treatment of Induced Panic Attack
Interventions
DRUG

Inhaled placebo

Inhaled Staccato Alprazolam Placebo

DRUG

Inhaled alprazolam 1 mg

Inhaled Staccato Alprazolam 1 mg

DRUG

Inhaled alprazolam 2 mg

Inhaled Staccato Alprazolam 2 mg

DRUG

IV doxapram

0.5 mg/kg doxapram IV approximately 10s after receiving inhaled alprazolam or placebo

Trial Locations (3)

10021

New York State Psychiatric Institute, New York

10029

Mt. Sinai School Of Medicine, New York

11203-2056

SUNY Downstate Medical Center, Brooklyn

Sponsors
All Listed Sponsors
lead

Alexza Pharmaceuticals, Inc.

INDUSTRY